心臓浮腫（うっ血性心不全）治療におけるOPC-41061の用量探索試験

基本情報

NCT ID

NCT00234104

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

122

治験依頼者名

Otsuka Pharmaceutical Co., Ltd.

概要

This drug is being developed to treat cardiac edema. The primary purpose of this study is to investigate the dose response for body weight in seven-day repeated oral administration of OPC-41061 at 15, 30, and 45 mg or placebo in patients with extracellular volume expansion secondary to CHF despite taking furosemide at 40 mg/d or more. This study is being conducted in Japan.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)